A composition comprising a glp-1 receptor agonist for preventing or treating a metabolic disease

TW202641518APending Publication Date: 2026-10-16YUNOVIA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115100995
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-01-10
Filing Date
2026-01-09
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080910_001
    Figure TWG2TA001080910_001
  • Figure TWG2TA001080910_002
    Figure TWG2TA001080910_002
  • Figure TWG2TA001080910_003
    Figure TWG2TA001080910_003
Patent Text Reader

Abstract

This invention relates to a pharmaceutical composition for the prevention or treatment of metabolic diseases, comprising an effective therapeutic amount of a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof, wherein the composition provides an appropriate dosage and method of administration to demonstrate optimal preventive or therapeutic effects in subjects suffering from metabolic diseases, preferably diabetes (especially type 2 diabetes), obesity, or overweight with weight-related complications.
Need to check novelty before this filing date? Find Prior Art